Advancing Early Detection in Pancreatic Cancer: A Conversation with Dr. Raymond Wadlow

In this in-depth conversation, Sergey Badalyan speaks with Dr. Raymond Wadlow - a Medical Oncologist at Inova Schar Cancer Institute, Co-Director of the GI Oncology Research Program and an Investigator with the PRECEDE Consortium, about the evolving landscape of pancreatic cancer research and the urgent need for earlier detection. Pancreatic cancer remains one of the most challenging malignancies, with a five-year survival rate of about 13%, largely due to late diagnosis. In this discussion, Dr. Raymond Wadlow explains how global collaboration, large-scale data sharing, and emerging technologies are helping researchers move closer to effective early detection strategies. The conversation highlights how international research initiatives and collaborative infrastructure are transforming how scientists study pancreatic cancer risk, screening, and prevention. #CancerImmunotherapy #ImmunoOncology #CancerResearch #CRI #CancerResearchInstitute #AIinHealthcare #PrecisionOncology #TranslationalResearch #SingleCellSequencing #SpatialTranscriptomics #ClinicalResearch #CancerBiology #GlobalHealth #OncologyInnovation #OncoDaily SUBSCRIBE to get the latest #oncodaily    / @oncodailytv   Visit the OncoDaily Website : https://oncodaily.com Like OncoDaily on LinkedIn:   / oncodaily   Like OncoDaily on X (Twitter): https://x.com/oncodaily Follow OncoDaily on Instagram:   / oncodailynews   Follow OncoDaily on TikTok:   / oncodaily   Like OncoDaily on Facebook:   / oncodaily   SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter About OncoDaily OncoDaily is your trusted source for the latest oncology news, expert interviews, patient stories, and cutting-edge research. Our mission is to empower the global cancer community—patients, survivors, professionals, and advocates—with timely, credible information. Subscribe for weekly podcasts, expert conversations, and updates on groundbreaking cancer research. 🔔 New videos every day! 💻 Visit us at https://oncodaily.com/